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A R T I C L E I N F O A B S T R A C T
Original article Objective(s): Stem cell differentiation into different cell lineages depends upon several factors, cell cycle
control elements and intracellular signaling elements, including P15INK4b and P16INK4a genes.
Epigenetics may be regarded as a control mechanism which is affected by these factors with respect to
their promoter structure.
Materials and Methods: The CD34 + cord blood stem cells were purified, isolated and then expanded.
The undifferentiated day genome was isolated from part of the cultured cells, and the seventh day
differentiated genome was isolated from the other part after differentiation to erythroid lineage. The
procedure was followed by a separate Real-Time PCR for the two genes using the obtained cDNA. The
processed DNA of the former stages was used for MSP (Methylation Specific PCR) reaction. Finally,
pre- and post differentiation results were compared.
Results: After performing MSP for each gene, it became clear that P15INK4b gene has undergone
methylation and expression in predifferentiation stage. In addition, its status has not been changed after
differentiation. P15INK4b gene expression was reduced after the differentiation. The other gene,
P16INK4a, showed no predifferentiation methylation. Itwas completely expressed methylated and
underwent reduced expression after differentiation.
Conclusion: Specific predifferentiation expression of P15INK4b and P16INK4a genes along with
reduction in their expression after erythroid differentiation indicated animportant role for these two
genes in biology of CD34+ cells in primary stages and before differentiation. In addition, both genes are
capable of epigenetic modifications due to the structure of their promoters.
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Please cite this paper as:Azad M, Kaviani S, Noruzinia M, Mortazavi Y, Mobarra N, Alizadeh Sh, Shahjahani M, Skandari F, Ahmadi MH, Atashi A, Abroun S,  Zonoubi Z.Gene Expression Status and Methylation Pattern in Promoter of P15INK4b and P16INK4a in Cord Blood CD 34 + Stem Cells Iran JBasic Med Sci; 2013; 16: 822-828.IntroductionInvestigations about the formation mechanismsof different cell types has led tounderstanding of the general mechanisms oftranscription and regulation of  the gene expression(1-3). In fact, differentiation process in primitivecells depends on the control of gene expression andprecise regulation of the intracellular signaling. Inthis context, the requirement of specific controlfactors such as cytokines, specific transcriptionfactors and cell cycle control elements is establishedand may be expected (4-8). Two of these factorsclassified as tumor suppressor proteins include
cyclin-dependent kinase inhibitors of 2A and 2Btypes, respectively, known as P16INK4a andP15INK4b. P16INK4a or P16 is a tumor suppressorprotein and cell cycle control element. A study byMinami (2003) highlighted the role of P16in hematopoiesis. They showed that this gene wasable to induce differentiation and apoptosis inerythroid lineage (9). CDK-4 and CDK6 arepotentially inhibited by P16, therefore, the mdm 2is not activated, and P53 protein (degraded innormal conditions by mdm 2) remains intact in theseconditions and may suppress the activity of tumors(9-12). The genes related to P15 and P16 are
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